The American Journal of Medicine
Volume 122, Issue 10, Supplement , Pages S13-S21 , October 2009

Assessment of Neuropathic Pain in Primary Care

  • Maija L. Haanpää, MD, PhD

      Affiliations

    • Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland
    • Rehabilitation ORTON, Helsinki, Finland
    • European Federation of Neurological Societies (EFNS) Panel on Neuropathic Pain, Vienna, Austria
    • Corresponding Author InformationRequests for reprints should be addressed to Maija L. Haanpää, MD, PhD, Department of Neurosurgery, Helsinki University Central Hospital, PO Box 266, 00029 HUS, Helsinki, Finland
    • ,
  • Misha-Miroslav Backonja, MD, PhD

      Affiliations

    • Department of Neurology, University of Wisconsin, Madison, Wisconsin, USA
    • ,
  • Michael I. Bennett, MB, ChB

      Affiliations

    • Institute of Health Research, Lancaster University, Lancaster University, Lancaster, United Kingdom
    • ,
  • Didier Bouhassira, MD, PhD

      Affiliations

    • Centre d'Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré 9, Boulogne-Billancourt, France
    • ,
  • Giorgio Cruccu, MD, PhD

      Affiliations

    • European Federation of Neurological Societies (EFNS) Panel on Neuropathic Pain, Vienna, Austria
    • Department of Neurological Sciences, La Sapienza University, Rome, Italy
    • ,
  • Per T. Hansson, MD, DMSc, DDS

      Affiliations

    • European Federation of Neurological Societies (EFNS) Panel on Neuropathic Pain, Vienna, Austria
    • Pain Center, Department of Neurosurgery, Section of Clinical Pain Research, Karolinska University Hospital and Institute, Stockholm, Sweden
    • ,
  • Troels Staehelin Jensen, MD, PhD

      Affiliations

    • European Federation of Neurological Societies (EFNS) Panel on Neuropathic Pain, Vienna, Austria
    • Danish Pain Research Center and Department of Neurology, Aarhus University Hospital, Aarhus, Denmark
    • ,
  • Timo Kauppila, MD, PhD

      Affiliations

    • Network of Academic Health Centers, Department of General Practice and Primary Health Care, Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland
    • Korso Health Care Center, Vantaa, Finland
    • ,
  • Andrew S.C. Rice, MB, BS, MD, FRCA, FFPMRCA

      Affiliations

    • Department of Anesthetics, Pain Medicine, and Intensive Care, Imperial College London, Chelsea & Westminster Hospital Campus, London, England, United Kingdom
    • ,
  • Blair H. Smith, MB, ChD, MD

      Affiliations

    • University of Aberdeen, Foresterhill Health Center, Aberdeen, Scotland, United Kingdom
    • ,
  • Rolf-Detlef Treede, Dr.med.

      Affiliations

    • Department of Neurophysiology, Center for Biomedicine and Medical Technology–Mannheim, Heidelberg University, Mannheim, Germany
    • ,
  • Ralf Baron, Dr.med.

      Affiliations

    • Division of Neurological Pain Research and Therapy, Department of Neurology, Universitatsklinikum Schleswig-Holstein, Kiel, Germany

References 

  1. Mäntyselkä P, Kumpusalo E, Ahonen R, et al. Pain as a reason to visit the doctor: a study in Finnish primary health care. Pain. 2001;89:175–180
  2. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain. 2000;84:95–103
  3. Cherry CL, Skolasky RL, Lal L, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology. 2006;66:867–873
  4. Murphy RA, Sunpath H, Kuritzkes DR, et al. Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary. J Infect Dis. 2007;196:S449–S456
  5. Haanpää M, Lockwood D, Hietaharju A. Neuropathic pain in leprosy. Lepr Rev. 2004;75:7–18
  6. Lacoux P, Ford N. Treament of neuropathic pain in Sierra Leone. Lancet Neurol. 2002;1:190–195
  7. Mijyawa M, Oniankitan O, Kolani B, Koriko T. Low back pain in hospital outpatients in Lomé (Togo). Joint Bone Spine. 2000;67:533–538
  8. Smyth K, Affandi JS, McArthur JC, et al. Prevalence and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med. 2007;8:367–373
  9. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976–982
  10. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–1522
  11. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911–1920
  12. Galil K, Choo PW, Donahue DVM, Platt R. The sequelae of herpes zoster. Arch Intern Med. 1997;157:1209–1213
  13. Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104:1–13
  14. Jääskeläinen S, Teerijoki-Oksa T, Virtanen A, Tenovuo O, Forssell H. Sensory regeneration following intraoperatively verified trigeminal nerve injury. Neurology. 2004;62:1951–1957
  15. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 2006;122:156–162
  16. Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain. 1995;61:187–193
  17. Österberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis—prevalence and clinical characteristics. Eur J Pain. 2005;9:531–542
  18. Finnerup NB, Johannesen IL, Sindrup SH, et al. Pain and dysesthesia in patients with spinal cord injury: a postal survey. Spinal Cord. 2001;39:256–262
  19. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain. 2007;23:143–149
  20. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380–387
  21. Daniel HC, Narewska J, Serpell M, Hoggart B, Johnson R, Rice AS. Comparison of psychological and physical function in neuropathic pain and nociceptive pain: implications for cognitive behavioural pain management programs. Eur J Pain. 2008;12:731–741
  22. Verbeek JH. How can doctors help their patients to return to work?. PLos Med. 2006;3:e88
  23. Manktelow RT, Binhammer P, Tomat LR, Bril V, Szalai JP. Carpal tunnel syndrome: cross-sectional and outcome study in Ontario workers. J Hand Surg. 2004;29:307–317
  24. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence-based proposal. Pain. 2005;118:289–305
  25. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2:e164
  26. Attal N, Cruccu G, Haanpää M, et al. EFNS Task Force EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153–1169
  27. Torrance N, Smith BH, Watson MC, Bennett M. Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract. 2007;24:481–485
  28. Gore M, Dukes E, Rowbotham DJ, Tai KS, Leslie D. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Eur J Pain. 2007;11:652–664
  29. Treede R, Jensen T, Campbell J, et al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology. 2008;70:1630–1635
  30. Jensen T, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 2003;102:1–8
  31. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet. 1999;353:1959–1964
  32. Baron R, Binder A. How neuropathic is sciatica? (The mixed pain concept [in German]). Orthopade. 2004;33:568–575
  33. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin: results from a general population survey. J Pain. 2006;7:281–289
  34. Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006;29:1294–1299
  35. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618–1625
  36. Jackson KJ. Pharmacotherapy for neuropathic pain. Pain Pract. 2006;6:27–33
  37. Karjalainen K, Malmivaara A, Mutanen P, et al. Mini-intervention for subacute low back pain: two-year follow-up and modifiers of effectiveness. Spine. 2004;29:1069–1076
  38. Baron R. Mechanisms of disease: neuropathic pain—a clinical perspective. Nat Clin Pract Neurol. 2006;2:95–106
  39. Hansson P. Neuropathic pain: clinical characteristics and diagnostic workup. Eur J Pain. 2002;6(suppl A):47–50
  40. Hansson P, Laceranza M, Marchettini P. Aspects of clinical and experimental neuropathic pain: the clinical perspective. In:  Hansson P,  Fields EL,  Hill RG,  Marchettini P editor. Neuropathic Pain: Pathophysiology and Treatment. Seattle, WA: IASP Press; 2001;p. 1–18Progress in Pain Research and Management, vol 21
  41. Scadding JW. Clinical examination. In:  Cervero F,  Jensen T editor. Handbook of Clinical Neurology. Amsterdam: Elsevier; 2006;p. 385–395Pain, vol 81
  42. Treede RD. Pain and hyperalgesia: definitions and theories. In:  Cervero F,  Jensen T editor. Handbook of Clinical Neurology. Amsterdam: Elsevier; 2006;p. 3–10Pain, vol 81
  43. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127:199–203
  44. Rasmussen PV, Sindrup SH, Jensen TS, Bach FW. Symptoms and signs in patients with suspected neuropathic pain. Pain. 2004;110:461–469
  45. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147–157
  46. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6:149–158
  47. Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain. 2003;19:306–314
  48. Backonja MM, Krause SJ. Neuropathic pain questionnaire—short form. Clin J Pain. 2003;19:315–316
  49. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36
  50. Portenoy R. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin. 2006;22:1555–1565
  51. Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol. 2004;11:153–162
  52. Leffler AS, Kosek E, Hansson P. The influence of pain intensity on somatosensory perception in patients suffering from subacute/chronic lateral epicondylalgia. Eur J Pain. 2000;4:57–71
  53. Marshall SJ, Cox S, Rice A. Pain in human immunodeficiency virus and acquired immunodeficiency syndrome. In:  Ballentyne JC editors. Massachusetts General Handbook of Pain Management. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 446–450

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

 This work was supported in part by travel grants from NeuPSIG, the Special Interest Group on Neuropathic Pain of the International Association for the Study of Pain (IASP).

PII: S0002-9343(09)00395-7

doi: 10.1016/j.amjmed.2009.04.006

The American Journal of Medicine
Volume 122, Issue 10, Supplement , Pages S13-S21 , October 2009

Article Tools

* Image Usage & Resolution